Delving into the Latest Updates on PHP0101 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas

Eye Diseases

Active Indication

Presbyopia

Inactive Indication-

Originator Organization

Suzhou Pulekang Pharmaceutical Technology Co., Ltd.

Active Organization

Suzhou Pulekang Pharmaceutical Technology Co., Ltd.

Inactive Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

主要目的：评价PHP0101滴眼液在中国老视患者中的安全性和耐受性。次要目的：评价PHP0101滴眼液在中国老视患者中单次/多次给药的药代动力学特征；评价PHP0101滴眼液在中国老视患者中改善近视力的初步疗效；评价PHP0101滴眼液在中国老视患者中对远视力的影响。

[Translation]

Primary objectives: To evaluate the safety and tolerability of PHP0101 eye drops in Chinese presbyopic patients. Secondary objectives: To evaluate the pharmacokinetic characteristics of PHP0101 eye drops after single/multiple administration in Chinese presbyopic patients; To evaluate the preliminary efficacy of PHP0101 eye drops in improving near vision in Chinese presbyopic patients; To evaluate the effect of PHP0101 eye drops on distance vision in Chinese presbyopic patients.

Start Date-

Sponsor / Collaborator

Suzhou Pulekang Pharmaceutical Technology Co., Ltd.

100 Clinical Results associated with PHP0101

Login to view more data

100 Translational Medicine associated with PHP0101

Login to view more data

100 Patents (Medical) associated with PHP0101

Login to view more data

100 Deals associated with PHP0101

Login to view more data